# Subregional differences in the hippocampal transcriptomic response after penetrating traumatic brain injury in rats

**Authors:** Erik Lidin, Mårten Risling, Mattias K. Sköld

PMC · DOI: 10.3389/fneur.2025.1729794 · Frontiers in Neurology · 2026-02-23

## TL;DR

This study explores how different parts of the hippocampus respond at the gene level after penetrating brain injuries in rats, revealing region-specific molecular changes linked to injury and recovery.

## Contribution

The paper introduces subregion-specific transcriptomic profiling of the hippocampus after penetrating TBI, revealing distinct gene expression patterns in CA1, CA2, CA3, and the dentate gyrus.

## Key findings

- CA1 shows increased cell-cycle and gliogenesis-related gene expression, indicating cytoskeletal stress.
- CA2 exhibits immune activation with downregulated oxidative phosphorylation, suggesting immune-driven metabolic dysfunction.
- The dentate gyrus upregulates tissue repair genes, indicating a neuroprotective response.

## Abstract

Penetrating traumatic brain injuries, often caused by projectiles like shrapnel, have become increasingly common in modern warfare. These injuries have high mortality rates and can lead to severe, long-term neurological deficits. The hippocampus is composed of distinct subregions with unique transcriptomic profiles and cytoarchitecture, and its dysfunction after TBI is closely linked to neurological sequelae, including cognitive and memory impairments. While previous research has explored general brain responses to TBI, the specific molecular changes in individual hippocampal subregions in TBI remain poorly understood. To address this, we used laser-capture microdissection, RNA-sequencing, and differential gene expression matched with gene ontology analysis to investigate transcriptional responses in hippocampal subregions (CA1, CA2, CA3, and dentate gyrus) following high-velocity penetrating TBI in a rat model. Our findings reveal distinct gene expression patterns in each region, reflecting varied pathophysiological responses. CA1 exhibited increased expression of cell-cycle and gliogenesis-associated genes, indicating cytoskeletal stress and gliogenesis-associated signaling. CA2 showed strong immune activation, highlighting leukocyte signaling, MHC antigen processing, and complement pathways, coupled with downregulation of oxidative phosphorylation, suggesting immune-driven metabolic dysfunction. CA3 displayed a pronounced inflammatory profile, marked by TNF signaling and adhesion remodeling. In contrast, the dentate gyrus upregulated genes linked to tissue repair, including ECM stabilization and angiogenesis, suggesting a neuroprotective response. These results highlight the complex, subregion-specific balance between injury and repair mechanisms following TBI, with the hippocampus likely contributing to injury progression through its widespread neuronal connections. Understanding these molecular dynamics is essential for developing targeted interventions aimed at mitigating damage and promoting recovery, especially in the context of increasing high-velocity brain injuries due to modern conflict.

## Linked entities

- **Diseases:** traumatic brain injury (MONDO:0858950)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** A2m (alpha-2-macroglobulin) [NCBI Gene 24153] {aka A2MAC1, A2m1, A2maa, A2mb, Mam}, Olig2 (oligodendrocyte transcription factor 2) [NCBI Gene 304103], Cd44 (CD44 molecule) [NCBI Gene 25406] {aka CD44A, METAA, RHAMM}, Igfbp2 (insulin-like growth factor binding protein 2) [NCBI Gene 25662] {aka BRL-BP, IBP-2, IGFBP-2, ILGFBPA}, Tap1 (transporter 1, ATP binding cassette subfamily B member) [NCBI Gene 24811] {aka Abcb2, Cim, Tap2}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Ca2 (carbonic anhydrase 2) [NCBI Gene 54231] {aka Car2}, Timp1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 116510] {aka TIMP-1, Timp}, Cspg4 (chondroitin sulfate proteoglycan 4) [NCBI Gene 121021] {aka 4732461B14Rik, AN2, Cspg4a, NG2}, Cdc20 (cell division cycle 20) [NCBI Gene 64515] {aka p55cdc}, Fn1 (fibronectin 1) [NCBI Gene 25661] {aka FIBNEC, fn-1}, Prc1 (protein regulator of cytokinesis 1) [NCBI Gene 308761], Tubb4a (tubulin, beta 4A class IVa) [NCBI Gene 29213] {aka Tubb4}, Cd74 (CD74 molecule) [NCBI Gene 25599] {aka INVG34}, Serpinb9 (serpin family B member 9) [NCBI Gene 361241], Tubb6 (tubulin, beta 6 class V) [NCBI Gene 307351] {aka RGD1305887}, S100a4 (S100 calcium-binding protein A4) [NCBI Gene 24615] {aka 18A2, 42A, CAPL, MTS1, P9ka, PEL98}, Gpnmb (glycoprotein nmb) [NCBI Gene 113955], Trpc6 (transient receptor potential cation channel, subfamily C, member 6) [NCBI Gene 89823] {aka Trrp6}, Cdk1 (cyclin-dependent kinase 1) [NCBI Gene 54237] {aka Cdc2, Cdc2a}, Vim (vimentin) [NCBI Gene 81818], Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Itgb2 (integrin subunit beta 2) [NCBI Gene 309684] {aka Cd18}, Rara (retinoic acid receptor, alpha) [NCBI Gene 24705], Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Ptn (pleiotrophin) [NCBI Gene 24924] {aka HARP, Hbnf}, tumor necrosis factor [NCBI Gene 103694380], Casp4 (caspase 4) [NCBI Gene 114555] {aka Casp11}, Tubb2b (tubulin, beta 2B class IIb) [NCBI Gene 291081] {aka RGD1309427, Tubb2}, Ocln (occludin) [NCBI Gene 83497], Mt1a (metallothionein 1a) [NCBI Gene 24567] {aka Mt, Mt1}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Igflr1 (IGF-like family receptor 1) [NCBI Gene 499126] {aka RGD1563574, Tmem149}, Serpinf1 (serpin family F member 1) [NCBI Gene 287526] {aka Dmrs91, Pedf}, Notch1 (notch receptor 1) [NCBI Gene 25496] {aka NOTCH, TAN1}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Tyrobp (transmembrane immune signaling adaptor Tyrobp) [NCBI Gene 361537] {aka Karap}, Icam1 (intercellular adhesion molecule 1) [NCBI Gene 25464] {aka CD54, ICAM, RICAM-I}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Scn1b (sodium voltage-gated channel beta subunit 1) [NCBI Gene 29686], Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Gfap (glial fibrillary acidic protein) [NCBI Gene 24387], Lgals3 (galectin 3) [NCBI Gene 83781] {aka AGE-R3, CBP30, L-34, gal-3}, Fcgr3a (Fc gamma receptor 3A) [NCBI Gene 304966] {aka CD16-2, Fcgr4}, Ca1 (carbonic anhydrase 1) [NCBI Gene 310218] {aka CA-I, Car1}, C1s (complement C1s) [NCBI Gene 192262] {aka r-gsp}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 301227] {aka Trem2-Mia, Trem2-Mib}, Myo1f (myosin IF) [NCBI Gene 314654], C1qb (complement C1q B chain) [NCBI Gene 29687] {aka Adia}, Tspo (translocator protein) [NCBI Gene 24230] {aka Bzrp, MBR, PTBZR02, Ptbzr, RATPTBZR02}, Mt2 (metallothionein 2) [NCBI Gene 689415] {aka MT-2, MT-II, Mt2A}, Igf1r (insulin-like growth factor 1 receptor) [NCBI Gene 25718] {aka IGF-1 receptor, IGFIRC, Igfr1, JTK13}, C1qc (complement C1q C chain) [NCBI Gene 362634] {aka Adib, C1qg}, Cfh (complement factor H) [NCBI Gene 155012] {aka AMBP-1, AMBP1, Fh}, Nfkbiz (NFKB inhibitor zeta) [NCBI Gene 304005] {aka Mail, RGD1310834}, Hspb1 (heat shock protein family B (small) member 1) [NCBI Gene 24471] {aka Hsp25, Hsp27}, S100a6 (S100 calcium binding protein A6) [NCBI Gene 85247], Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 25361] {aka VCAM1B}, Ca3 (carbonic anhydrase 3) [NCBI Gene 54232] {aka Car3}, C1qa (complement C1q A chain) [NCBI Gene 298566] {aka Adic}
- **Diseases:** laceration (MESH:D022125), ischemic injury (MESH:D017202), Penetrating traumatic brain injury (MESH:D020197), hippocampal dysfunction (MESH:D001927), brain injuries (MESH:D001930), epilepsy (MESH:D004827), Gliosis (MESH:D005911), neurological sequelae (MESH:D009422), cognitive and memory dysfunction (MESH:D003072), amnesia (MESH:D000647), depression (MESH:D003866), neuronal death (MESH:D009410), edema (MESH:D004487), Neuroinflammatory (MESH:D000090862), TBI (MESH:D000070642), Mitochondrial dysfunction (MESH:D028361), head injuries (MESH:D006259), injury (MESH:D014947), inflammation (MESH:D007249), MR (MESH:D008944), ischemia (MESH:D007511), neurological deficits (MESH:D009461), seizure (MESH:D012640), metabolic dysfunction (MESH:D008659), affective disturbances (MESH:D019964)
- **Chemicals:** Lidocaine (MESH:D008012), O2 (-), aluminum (MESH:D000535), calcium (MESH:D002118), ROS (MESH:D017382), DAPI (MESH:C007293), Buprenorphine (MESH:D002047), NADH (MESH:D009243), PBS (MESH:D007854), paraformaldehyde (MESH:C003043), Marcaine (MESH:D002045), ATP (MESH:D000255), OCT (MESH:C051883), ethanol (MESH:D000431), cresyl violet (MESH:C028911), isoflurane (MESH:D007530), NaN3 (MESH:D019810), water (MESH:D014867)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rattus (rat, genus) [taxon 10114]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967967/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967967/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967967/full.md

---
Source: https://tomesphere.com/paper/PMC12967967